COMMUNIQUÉS West-GlobeNewswire
-
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
25/08/2026 -
Incuvate Files Patent Infringement Lawsuit Against Penumbra
25/08/2026 -
Acquisition of Own Shares
25/08/2026 -
Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072
25/08/2026 -
Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
25/08/2026 -
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
25/08/2026 -
Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
25/08/2026 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
25/08/2026 -
Voting Rights and Shares Capital of the Company
25/08/2026 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
25/08/2026 -
Informations sur le nombre total de droits de vote et d'actions
25/08/2026 -
Information on the total number of voting rights and shares
25/08/2026 -
VapoCept Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
25/08/2026 -
Perceptra, a Thai Startup, Brings Medical AI to International Markets to Enhance Regional Patient Screening
25/08/2026 -
University of Miami's Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
25/08/2026 -
Le Fonds Rio Tinto Canada investit 2 millions de dollars pour faire avancer l’innovation en santé au Québec
25/08/2026 -
Rio Tinto Canada Fund invests $2 million to advance healthcare innovation in Quebec
25/08/2026 -
BrewDog cumule les distinctions aux World Beer Awards 2026 et confirme l’excellence de son savoir-faire brassicole
25/08/2026 -
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
25/08/2026
Pages